Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia

Abstract

Background Chronic myeloid leukemia (CML) is a malignant hyperplastic tumor of the bone marrow originating from pluripotent hematopoietic stem cells. The advent of tyrosine kinase inhibitors (TKIs) has greatly improved the survival rate of patients with CML. However, TKI-resistance leads to the disease recurrence and progression. This study aimed to identify immune-related genes (IRGs) associated with CML progression. Methods We extracted the gene’s expression profiles from the Gene Expression Omnibus (GEO). Bioinformatics analysis was used to determine the differentially expressed IRGs of CML and normal peripheral blood mononuclear cells (PBMCs). Functional enrichment and gene set enrichment analysis (GSEA) were used to explore its potential mechanism. Hub genes were identified using Molecular Complex Detection (MCODE) and the CytoHubba plugin. The hub genes’ diagnostic value was evaluated using the receiver operating characteristic (ROC). The relative proportions of infiltrating immune cells in each CML sample were evaluated using CIBERSORT. Quantitative real-time PCR (RT-qPCR) was used to validate the hub gene expression in clinical samples. Results A total of 31 differentially expressed IRGs were identified. GO analyses revealed that the modules were typically enriched in the receptor ligand activity, cytokine activity, and endopeptidase activity. KEGG enrichment analysis of IRGs revealed that CML involved Th17 cell differentiation, the NF-kappa B signaling pathway, and cytokine-cytokine receptor interaction. A total of 10 hub genes were selected using the PPI network. GSEA showed that these hub genes were related to the gamma-interferon immune response, inflammatory response, and allograft rejection. ROC curve analysis suggested that six hub genes may be potential biomarkers for CML diagnosis. Further analysis indicated that immune cells were associated with the pathogenesis of CML. The RT-qPCR results showed that proteinase 3 (PRTN3), cathepsin G (CTSG), matrix metalloproteinase 9 (MMP9), resistin (RETN), eosinophil derived neurotoxin (RNase2), eosinophil cationic protein (ECP, RNase3) were significantly elevated in CML patients’ PBMCs compared with healthy controls. Conclusion These results improved our understanding of the functional characteristics and immune-related molecular mechanisms involved in CML progression and provided potential diagnostic biomarkers and therapeutic targets.

Identification of diagnostic biomarkers for idiopathic pulmonary hypertension with metabolic syndrome by bioinformatics and machine learning

“…This suggests that RNASE2 plays an important role in the immune system 29 . As an immune-related molecule, RNASE2 is a biomarker of various immune system diseases, including chronic myelogenous leukemia, systemic lupus erythematosus, rheumatoid arthritis, and multiple myeloma [30][31][32][33] . In terms of cancer, RNASE2 www.nature.com/scientificreports/ promotes the malignant progression of glioma through the PI3K/Akt signaling pathway 34 .…”

Comprehensive analysis of prognosis of cuproptosis-related oxidative stress genes in multiple myeloma

“…It inhibits ROS-induced apoptosis in cardiomyocytes via PI3K-Akt pathway (Ishii et al, 2015). In hematological cancers, it was significantly upregulated in CML patients' PBMCs compared with healthy controls (Yao et al, 2022). APOE (apolipoprotein E) is a known immune suppressant, which is significantly regulated in many human tumors, but its role in multiple myeloma has not been defined (Wu et al, 2022).…”

Tandem Mass Tag-Based Proteomic Profiling Identifies Biomarkers in Drainage Fluid for Early Detection of Anastomotic Leakage after Rectal Cancer Resection

“…19 Moreover, the expression of RETN was significantly associated with immune cell disorders. 20 Thus, to investigate the influence of RETN on the immune response, we determined whether RETN affected the Jurkat cells' secretion of cytokines. The results indicated that RETN increased the expression of IL-2 and IFN-γ, suggesting that RETN enhances the immune activity of the Jurkat cells.…”

“…RETN is a family member of mouse resistin-like genes that displays antibacterial activity in the skin against both Gram-positive and Gram-negative bacteria . Moreover, the expression of RETN was significantly associated with immune cell disorders . Thus, to investigate the influence of RETN on the immune response, we determined whether RETN affected the Jurkat cells’ secretion of cytokines.…”